NSPR - InspireMD - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NSPR is currently covered by 1 analysts with an average price target of $5. This is a potential upside of $2.21 (79.21%) from yesterday's end of day stock price of $2.79.

InspireMD's activity chart (see below) currently has 9 price targets and 8 ratings on display. The stock rating distribution of NSPR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.5% with an average time for these price targets to be met of 63 days.

Highest price target for NSPR is $4, Lowest price target is $4, average price target is $4.

Most recent stock forecast was given by ADAM MAEDER from PIPER SANDLER on 12-May-2025. First documented stock forecast 16-Oct-2020.

Best performing analysts who are covering NSPR - InspireMD:

Ben Haynor Adam Maeder

Currently out of the existing stock ratings of NSPR, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$4

$1.21 (43.37%)

$4.5

2 months 21 days ago
(12-May-2025)

1/4 (25%)

$1.42 (55.04%)

30

Buy

$4.75

$1.96 (70.25%)

$5.15

2 years 2 months 16 days ago
(17-May-2023)

1/5 (20%)

$2.99 (169.89%)

96

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NSPR (InspireMD) average time for price targets to be met?

On average it took 63 days on average for the stock forecasts to be realized with a an average price target met ratio 22.5

Which analyst has the current highest performing score on NSPR (InspireMD) with a proven track record?

BEN HAYNOR

Which analyst has the current lower performing score on NSPR (InspireMD) with a proven track record?

ADAM MAEDER

Which analyst has the most public recommendations on NSPR (InspireMD)?

Ben Haynor works at LAKE STREET and has 17 price targets and 9 ratings on NSPR

Which analyst is the currently most bullish on NSPR (InspireMD)?

Ben Haynor with highest potential upside - $1.96

Which analyst is the currently most reserved on NSPR (InspireMD)?

Adam Maeder with lowest potential downside - $1.21

InspireMD in the News

InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors

MIAMI, July 31, 2025 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the appointment of Raymond W. Cohen to its Board of Directors. Mr. Cohen has over 40 years of leadership experience in medical technology with a...

InspireMD Reports First Quarter 2025 Financial Results

MIAMI, May 09, 2025 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced financial and operating results for the first quarter ended March 31, 2025. BusinessHighlights: Continued engagement with the U.S. Food and Drug Administration (FDA)...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?